Catecholamines - Spot Urine
- C1293
Rs 4180
- Why Get Tested?
To help confirm or rule out a rare adrenal tumor called a pheochromocytoma or a rare extra-adrenal tumor called a paraganglioma; these tumors produce excess hormones called catecholamines, which are broken down to metanephrines. - When To Get Tested?
After or in conjunction with plasma free metanephrines and/or urine metanephrines tests and when your healthcare provider needs additional information regarding a possible catecholamine-secreting tumor - Sample Type:Urine
- Fasting :NO
- Report Delivery:within 48 Hrs of Test Schdule
- Components:1 Observations
Tests Detail
| Observations Included |
| Catecholamines - 24 Hrs Urine |
| The Test marked with (*) are in our NABL Scope. |
Sample Report
- Also Known As:
Dopamine Epinephrine Norepinephrine Free Catecholamines, plasma and urine Fractionated Catecholamine - Formal Name:
Catecholamines, Plasma and Urine - Sample Instructions:
A 24-hour urine sample; sometimes a blood sample drawn from a vein in your arm - Test Preparation Needed?
These tests are affected by certain drugs, foods, and stresses. Inform your healthcare provider of any medications you are taking and follow any preparation instructions you are given before sample collection. Although you may be seated for collection of the blood sample, it is recommended that you be lying down. Your healthcare provider or the collection site will instruct you as to their specific requirements. - What Is Being Tested?
Catecholamines are a group of similar hormones released into the bloodstream in response to physical or emotional stress. The primary catecholamines are dopamine, epinephrine (adrenaline), and norepinephrine. Catecholamine testing measures the amounts of these hormones in the urine and/or blood. Urine testing is recommended over blood testing. Just the stress of having blood drawn can increase catecholamine blood levels, so results from blood tests are not as reliable as results from urine tests. Catecholamines are produced in the adrenal medulla, the interior portion of the adrenal glands, and released into the blood. The adrenal glands are small, triangular organs located on top of each kidney. Catecholamines are also produced by cells of the sympathetic nervous system. They are released into the bloodstream in response to physical and emotional stress. They help transmit nerve impulses in the brain, increase glucose and fatty acid release for energy, dilate bronchioles, and dilate the pupils. Norepinephrine also constricts blood vessels, causing increased blood pressure, and epinephrine increases heart rate and metabolism. After completing their actions, catecholamines are metabolized to inactive compounds. Dopamine becomes homovanillic acid (HVA), norepinephrine breaks down into normetanephrine and vanillylmandelic acid (VMA), and epinephrine becomes metanephrine and VMA. Both the hormones and their metabolites are eliminated from the body in the urine. Normally, catecholamines and their metabolites are present in the body in small, fluctuating amounts that only increase appreciably during and shortly after a stressful situation. However, rare tumors called pheochromocytomas and paragangliomas can produce large amounts of the hormones, resulting in increased concentrations in both the blood and urine. This can cause persistent or sudden bursts of hypertension, which may lead to severe headaches. Other symptoms include heart palpitations, sweating, nausea, anx - How Is It Used?
Catecholamines testing may be used in follow up to plasma free metanephrines and/or urine metanephrines testing to help confirm or rule out rare tumors called pheochromocytomas and paragangliomas in symptomatic people. It also may be ordered when a tumor is treated or removed to monitor for recurrence. Catecholamines are a group of similar hormones that are released into the bloodstream in response to physical or emotional stress. The primary catecholamines are dopamine, epinephrine (adrenaline), and norepinephrine. These hormones are broken down to their metabolites metanephrine, normetanephrine, homovanillic acid, and vanillylmandelic acid. (See the "What is being tested?" section for more on this.) Pheochromocytomas and paragangliomas produce these hormones in excess, so measuring the amount in the blood and/or urine may help detect the tumor. The Endocrine Society recommends tests for plasma free metanephrines and urine metanephrines to evaluate an individual for pheochromocytomas or paragangliomas. If results of those tests are inconclusive, then urine testing for catecholamines may be used to provide additional information. Blood catecholamine testing may sometimes be used, but it is not as reliable because the stress of having blood drawn can increase levels. Urine catecholamines testing measures the total amount of catecholamines released into the urine in 24 hours. Since the hormone levels may fluctuate significantly during this period, the urine test may detect excess episodic production that is missed with the blood test. The catecholamine blood test may be useful when the person has persistent hypertension or is currently experiencing a sudden burst (paroxysm) of hypertension. This is because the hormones do not stay long in the blood; they are used by the body and rapidly broken down (metabolized) and/or then eliminated. The test for catecholamines is very sensitive and false positives do occur. The test is affected by stress, drugs, smoking, and v - When Is It Ordered
Catecholamines testing may be ordered when tests for plasma free metanephrines and/or urine metanephrines are inconclusive and a health practitioner needs more information about a possible catecholamine-secreting tumor. It may be ordered when a person, especially a relatively young person (younger than age 40) has sudden bursts (paroxysms) of signs and symptoms such as: High blood pressure (hypertension), especially when a person has hypertension that is not responding to treatment, as people with pheochromocytomas and paragangliomas are frequently resistant to conventional therapies Severe headaches Sweating Flushing Rapid heart rate (palpitations) Tremor The tests may also be ordered for an asymptomatic person if an adrenal or neuroendocrine tumor is detected during a scan conducted for another purpose or if the person has a strong personal or family history of pheochromocytoma. It may also be ordered at intervals when a person has been previously treated for one of these tumors. - What Does The Test Result Mean?
A high level of catecholamines in the blood and/or urine in a person with signs and symptoms strongly suggests the presence of a catecholamine-secreting tumor. It indicates that further investigation is needed. It is recommended that imaging studies be performed to locate the catecholamine-secreting tumor once there is clear biochemical evidence of such a tumor. If catecholamine levels are elevated in a person who has been treated for a catecholamine-secreting tumor, then it is likely that either treatment was not fully effective or that the tumor is recurring and appropriate follow up is needed. If the level of catecholamines is normal, then it is unlikely that a person has a catecholamine-secreting tumor. However, pheochromocytomas do not necessarily produce catecholamines at a constant rate. Therefore, if the person has not had a recent episode of hypertension, their blood and urine concentrations of catecholamines could be at normal or near normal levels even when a pheochromocytoma is present. If suspicion remains high, testing may be repeated. - Is There Anything Else I Should Known?
While plasma and urine catecholamines tests can help detect and diagnose catecholamine-secreting tumors, they cannot tell the location of the tumor, whether there is more than one, or whether or not the tumor is benign (although most are). The total amount of catecholamines produced will tend to increase as the tumor increases in size or number. Although pheochromocytomas and extra-adrenal paragangliomas are rare, 25% occur in the setting of a hereditary syndrome associated with alterations in specific genes. These genetic syndromes have thus been identified as carrying an increased tumor risk. Examples include MEN-1 and MEN-2 (Multiple Endocrine Neoplasia, types 1 and 2) syndromes. (For more information on these, see Genetics Home Reference: Multiple Endocrine Neoplasia.) It has been proposed that all patients diagnosed with a pheochromocytoma or extra-adrenal paraganglioma should consider genetic counseling and testing. Early identification of a hereditary syndrome allows for early screening for other associated tumors. In addition, some patients with a hereditary syndrome are more likely to develop malignant or recurrent disease. Knowledge of the specific genetic mutation permits increased vigilance during preoperative localization or postoperative surveillance of such patients. It is also recommended that if a mutation is identified, predictive genetic testing should be offered to asymptomatic at-risk family members. A variety of medications can interfere with catecholamines testing. However, it is important to talk to your healthcare provider before discontinuing any prescribed medications. Your healthcare provider will work with you to identify potentially interfering substances and drug treatments and to determine which of them can be safely interrupted and which must be continued for your well-being. Tests used for determining the presence of catecholamine-secreting tumors (pheochromocytomas and paragangliomas) include plasma catecholamines, urine catec
Frequently Booked Test
Absolute Eosinophil Count
-
C1214
-
5-a-Dihydrotestosterone (5a DHT)
-
within 72 Hrs of Test Schdule
₹ 350.00
Absolute Eosinophil Count
-
C1214
-
5-a-Dihydrotestosterone (5a DHT)
-
within 72 Hrs of Test Schdule
₹ 350.00
Absolute Eosinophil Count
-
C1214
-
5-a-Dihydrotestosterone (5a DHT)
-
within 72 Hrs of Test Schdule
₹ 350.00